Home » Topics » BioWorld Science

BioWorld Science
RSS

NeuroVia initiates phase I/II trial of NV-1205 in childhood cerebral adrenoleukodystrophy

June 11, 2018

Saniona to study Tesomet in phase IIa trial for hypothalamic obesity

June 11, 2018

First-in-human study evaluates AZD-4205 with osimertinib in advanced NSCLC

June 11, 2018

MaxCyte and NIH enter CRADA for sickle cell disease

June 11, 2018

Responses to M-7824 in phase I study lead to phase II trial in HPV-associated cancers

June 11, 2018

Tagrisso approved in E.U. for first-line EGFR-mutated NSCLC

June 11, 2018

Evgen offers interim update from phase II STEM trial of SFX-01 in advanced breast cancer

June 11, 2018

EBX-205, a new oral broad-spectrum antibiotic active against bioterrorism pathogens

June 11, 2018

Idorsia initiates phase II registration program for nemorexant in insomnia

June 11, 2018

FDA approves Venclexta plus rituximab for previously treated CLL and SLL

June 11, 2018

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...